Every year, malaria causes approx 500 million cases of acute illness resulting in more than a million deaths worldwide. Malaria is a deadly disease that can kill within hours following few days of incubation.
Considering the seriousness and huge prevalence of malaria in Pakistan, OBS Pakistan (Pvt.) ltd is proud to launch its first Anti-malarial drug, by the name of “ARTRINE”.
ARTRINE is a combination of Artemether and Lumefantrine, making it a fast eliminator of malarial parasite; therefore symptoms of malaria do not progress to complications.
A dynamic launch was held on 9th and 10th June 2014 in Lahore, where the CV-1 team participated with great confidence and excitement. The launch started with the name of Allah, followed by a cake cutting celebration and commitment of the team to make ARTRINE a national leader in anti-malarial drugs.
The training sessions had Product & Disease trainings, based on which the marketing and promotional strategies were shared with the sales team. The sales team found these sessions very helpful and easy to understand through which they realized the importance of ARTRINE in elimination of malaria in Pakistan. The sessions were concluded with an aggressive and very energetic detailing competition, where PSOs and RMs participated in detailing of the promotional folders.
This internal launch meeting was followed by joint Sales and Marketing team’s external launch program across Pakistan, where the leading physicians were engaged at in-chamber launch ceremony, followed by detailed discussion on ARTRINE and its benefits to the patients.
ARTRINE is an important addition to the General team, especially for CV-1 and we are sure that it will be the drug of choice for the HCPs and their patients to fight against malaria.